Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency

American Journal of Public Health

Volumn 88, Issue 1, 1998, Pages 34-39

  Rhoades, Howard M ^a   Creson, Dan ^a   Elk, Ronith ^a   Schmitz, Joy ^a   Grabowski, John ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; METHADONE;

ADULT; ARTICLE; CONSULTATION; DRUG DEPENDENCE; DRUG USE; FEMALE; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; SURVIVAL;

EID: 0031934395     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.88.1.34     Document Type: Article

References (20)

1. Dole VP, Nyswander ME. A medical treatment for diacetyl-morphine(heroin) addiction. JAMA. 1965;193:646.
2. Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med. 1966;118:304-309.
3. Dole VP, Joseph H. Long-term outcome of patients treated with methadone maintenance. Ann N Y Acad Sci. 1978;311:181-189.
4. Yarmolinsky A, Pechura CM. Methadone revisited. Issues Sci Technol. Spring 1996;38-42.
5. Hartel DM, Schoenbaum EE, Selwyn PA, et al. Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health. 1995; 85:83-88.
6. Nadelmann E, McNeely J. Doing methadone right. The Public Interest. Spring 1966;123: 83-95.
7. Grabowski J, Rhoades H, Elk R, et al. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled, double-blind trials. J Clin Psychopharmacol. 1995; 15:163-174.
8. Senay EC, Barthwell AG, Marks R, Boros P, Gillman D, White G. Medical maintenance: a pilot study. J Addict Dis. 1993;12:59-76.
9. Cooper J. Methadone treatment in the United States. In: Arif A, Westermeyer J, eds. Methadone in the Management of Opioid Dependence: Program Policies around the World. Minneapolis, Minn: University of Minnesota Press; 1988:139-153.
10. Cooper JR Establishing a methadone quality assurance system: rationale and objectives. In: Pickens R, Leukefeld G, Schuster CR, eds. Improving Drug Abuse Treatment. Washington, DC: US Dept of Health and Human Services; 1991:358-364. USDHHS ADM91-1754. National Institute on Drug Abuse Research Monograph 106.
11. Woody GE, O'Brien CP. Update on methadone maintenance. In: Miller N, ed. Comprehensive Handbook of Drug and Alcohol Addiction. New York, NY: Marcel Dekker, Inc; 1991: 1113-1125.
12. Stitzer M, Kirby K. Reducing illicit drug use among methadone patients. In: Pickens R, Leukefeld G, Schuster CR, eds. Improving Drug Abuse Treatment. Washington, DC: US Dept of Health and Human Services; 1991:178-203. USDHHS ADM 91-1754, National Institute on Drug Abuse Research Monograph 106.
13. Rettig R, Yarmolinsky A, eds. Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press; 1995.
14. Stitzer M, Bigelow GE, Liebson IA, McCaul ME. Contingency management of supplemental drug use during methadone maintenance treatment. In: Grabowski J, Stitzer M, Henningfield J, eds. Behavioral Intervention Techniques in Drug Abuse Treatment. Washington, DC: US Dept of Health and Human Services; 1984:84-103. USDHHS ADM 84-1282. National Institute on Drug Abuse Research Monograph 46.
15. Elk R, Grabowski J, Rhoades HM, McLellan AT. A substance abuse research-treatment clinic. Subst Abuse Treatment. 1993;10:459-471
16. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38: 963-974.
17. Little RJA, Rubin DB. Statistical Analysis with Missing Data. New York, NY: John Wiley & Sons; 1987.
18. Dixon WJ, Merdian KL. ANOVA and Regression with BMDP 5V. Los Angeles, Calif: Dixon Statistical Associates; 1992.
19. Grabowski J, Rhoades H, Elk R, et al. Methadone treatment and cocaine dependence. Am J Psychiatry. 1993;150:675.
20. Stine SM, Burns B, Kosten T. Methadone dose for cocaine abuse. Am J Psychiatry. 1991;148:1268.